Néant, Nadège <br/><br/>
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.  [electronic resource] 

 -  European journal of clinical pharmacology  Apr 2018 
 - 473-481 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1432-1041 
<br/><br/><label>Standard No.: </label>10.1007/s00228-017-2405-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-HIV Agents--administration & dosage<br/>Area Under Curve<br/>Chromatography, Liquid<br/>Computer Simulation<br/>Drug Dosage Calculations<br/>Drug Monitoring--methods<br/>Emtricitabine, Rilpivirine, Tenofovir Drug Combination--administration & dosage<br/>Female<br/>France<br/>HIV Infections--blood<br/>HIV-1--drug effects<br/>Half-Life<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Models, Biological<br/>Nonlinear Dynamics<br/>Retrospective Studies<br/>Software<br/>Tablets<br/>Tandem Mass Spectrometry<br/>Young Adult